PTCT PTC Therapeutics Inc

PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.

$40.17  +0.06 (0.15%)
As of 06/24/2022 15:59:52 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/20/2013
Outstanding shares:  71,338,279
Average volume:  1,117,374
Market cap:   $2,861,378,371
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B17VCN9
Valuation   (See tab for details)
PE ratio:   -5.50
PB ratio:   2,011.00
PS ratio:   5.03
Return on equity:   576.26%
Net income %:   -91.68%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy